News

Akorn Issues Voluntary Nationwide Recall of Various Human and Animal Drug Products Within Expiry Due to Company Shutdown

April 26, 2023

Read More »

Vowst

April 26, 2023

Read More »

Qalsody

April 25, 2023

Read More »

FDA clarifies pharmacist recommendations in Buprenorphine for Opioid Dependence REMS

April 19, 2023

Read More »

Novartis Announces Positive Topline Results for Kisquali as Adjuvant Treatment for Early Breast Cancer

April 19, 2023

Read More »

FDA Adds Quinacrine Hydrochloride (quinacrine) to the List of Bulk Drug Substances that May Be Used in Compounding by Outsourcing Facilities (503B Bulks List)

April 19, 2023

Read More »

Update on Insulin Prices and Pipeline Products

April 19, 2023

Read More »

Ascend Laboratories LLC Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

April 19, 2023

Read More »

Omisirge

April 17, 2023

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA